METTL3 modulates cell viability and motility in HCC1143 and MDA-MB-231 triple-negative breast cancer cells
The m6A methyltransferase METTL3 functions as a critical oncogenic driver in triple-negative breast cancer (TNBC). However, its specific downstream targets and mechanistic functions in less metastatic TNBC subtypes remain poorly characterized. To address this, we evaluated METTL3 expression and the phenotypic effects o...